Marker Therapeutics (MRKR) Construction in Progress (2020 - 2022)

Marker Therapeutics (MRKR) has 3 years of Construction in Progress data on file, last reported at $4.1 million in Q1 2022.

• Construction in Progress for Q1 2022 came in at $4.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $4.1 million (changed N/A YoY), and the FY2021 annual result was $2.2 million, down 67.26% from the prior year.
• Construction in Progress advanced to $4.1 million in Q1 2022 per MRKR's latest filing, from $2.2 million in the prior quarter.
• Over five years, Construction in Progress peaked at $6.8 million in Q4 2020 and troughed at $2.2 million in Q3 2021.
• A 3-year average of $3.8 million and a median of $3.4 million in 2020 frame the typical range for Construction in Progress.
• On a YoY basis, Construction in Progress climbed as much as 52.17% in 2021 and fell as far as 67.26% in 2021.
• A 3-year view of Construction in Progress shows it stood at $6.8 million in 2020, then plunged by 67.26% to $2.2 million in 2021, then jumped by 83.7% to $4.1 million in 2022.
• Business Quant data shows MRKR's Construction in Progress at $4.1 million in Q1 2022, $2.2 million in Q4 2021, and $2.2 million in Q3 2021.